LINK Medical announced today the transfer of specific business areas from SDS Life Science AB (an affiliate of Cytel Inc.), namely the Drug Development Consulting and Clinical Project Management/Medical Writing units. The transfer enables LINK Medical to further support Nordic biotech companies with both strategic drug development expertise and robust operational execution. This transfer does not include biometrics or commercialization-related capabilities, enabling Cytel to maintain its strategic focus and continue serving the Nordic market as a leading provider of quantitative and real-world evidence solutions.
Through this transfer, clients will gain access to a complete and seamless development partner – offering early-stage development strategy, regulatory guidance covering all non-clinical aspects of development (CMC, pharmacology, pharmacokinetics, and toxicology), medical writing, and clinical project execution from First-in-Man to late-stage development under one coordinated structure. The combined strengths allow for faster project initiation, efficient delivery, and a clearer regulatory and operational pathway throughout the development process.
“This transfer reinforces our core mission: helping Nordic biotech companies accelerate their drug development with high-quality, integrated expertise, and strong local presence,” says Anders Göransson, CEO of LINK Medical.
“This is an excellent fit, and we are excited to become part of LINK Medical. Together, we strengthen our ability to drive complex development programs from start to finish,” says Maria Lundberg, who is also transitioning from SDS to LINK Medical as Early-Stage Services & Integration Lead.
The transfer of selected operations from SDS Life Science AB is fully aligned with LINK Medical’s strategy to strengthen its position as the most trusted and comprehensive development partner in the Nordic region.
About LINK Medical
LINK Medical was founded in 1995 and has a presence in Norway, Sweden, Denmark, Finland, Germany, and the UK. LINK Medical is a leading Nordic CRO and Regulatory Service provider, offering a wide range of flexible expert services and innovative technologies for the biotech, pharmaceutical, medical device industries, as well as other CROs across Northern Europe and beyond. As a Nordic full-service CRO and Regulatory Service provider with international reach, LINK Medical supports all stages of product development, from pre-clinical to marketing approval, and has built a network of trusted partners to ensure international coverage.
For further information:
Anders Göransson, CEO, LINK Medical
anders.goransson@linkmedical.eu, +46 70 23 89 576
Maria Lundberg, Early-Stage Services & Integration Lead, LINK Medical
maria.lundberg@linkmedical.eu, +46 70 259 83 84
linkmedical.eu
